MAPT and Alzheimer disease: Our study is the largest autopsy series to date, which allowed us to validate longitudinal plasma biomarkers against autopsy-confirmed diagnoses, examine specific associations with AD and other pathologies, and compare performance of plasma total tau, P-tau181 and P-tau231.